GRAFT VERSUS HOST DISEASE IN SKIN

Clinical trials for GRAFT VERSUS HOST DISEASE IN SKIN explained in plain language.

Never miss a new study

Get alerted when new GRAFT VERSUS HOST DISEASE IN SKIN trials appear

Sign up with your email to follow new studies for GRAFT VERSUS HOST DISEASE IN SKIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a skin biopsy reveal how axatilimab fights scarring in chronic GVHD?

Knowledge-focused Not yet recruiting

This study investigates how axatilimab, an FDA-approved drug for chronic graft-versus-host disease (cGVHD), changes immune cells in the skin. Researchers will analyze skin and blood samples from 15 adults with skin cGVHD—10 starting axatilimab and 5 not receiving it—to understand…

Matched conditions: GRAFT VERSUS HOST DISEASE IN SKIN

Sponsor: Northwestern University • Aim: Knowledge-focused

Last updated Aug 14, 2026 00:00 UTC

GRAFT VERSUS HOST DISEASE IN SKIN

Get alerted when new GRAFT VERSUS HOST DISEASE IN SKIN trials appear

Can a skin biopsy reveal how axatilimab fights scarring in chronic GVHD?